Studies have shown that c-Jun N-terminal kinase (JNK), a key member of the MAPK signaling pathway, is associated with tumor progression and survival in various cancers (18–20) and contributes to the growth of PCa (21). This evidence concerns the gene MAPK8 and cancer.